Clinical Trial Update: Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age [Phase 3]

View source ↗

Summary

Phase 3 trial results for Genotonorm to improve height in children born small with fetal growth restriction have been posted by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• Genotonorm (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Fetal Growth Retardation | Phase 3 | Status: COMPLETED | Results posted: 2010-06-04